Abstract
The aim of this study was to evaluate the outcome of patients with soft tissue sarcoma of the extremity and abdominal wall. This is the retrospective analysis of patients from a prospectively maintained data base from a single institute. We identified 79 patients with intermediate- to high-grade soft tissue sarcomas who were treated at our institute between Jan 2015 and July 2018. Low-grade tumors were excluded. There were 60 males and 19 females with a mean age of 44.6 years. Of the 79 sarcomas, 50 were in the lower limb and 24 in the upper limb and 5 were in abdominal wall. The commonest subtypes were undifferentiated pleomorphic sarcoma (n = 21) and synovial sarcoma (n = 19). Only 9 patients had metastatic disease at presentation. All 79 patients underwent surgical resection with an intent to achieve clear margins. Amputation was done in 19 patients while wide excision of the tumor was done in 60 patients. Adjuvant radiotherapy was given in 49 patients while adjuvant chemotherapy was given in 35 patients. At last follow-up (73 patients), 48 patients are alive without disease, 9 are alive with disease, 12 patients had died of disease, and 4 patients died due to other causes. Overall survival (OS) for 3 year is 77.6%, and estimated mean survival is 55.05 months. Relapse-free surviva (RFS)l at 3 year is 74.3%, and estimated mean RFS is 51.78. The only independent factor that affected the OS was the dimension of primary tumor (p = 0.02). For disease-free survival, the independent factors that affected outcome were stage at presentation (p = 0.04) and dimension of the tumor (p = 0.04). Short-term results shown by this study shows good outcome in patient with intermediate- to high-grade sarcomas when multidisciplinary approach is utilized for the management. Patients who had metastatic disease at presentation did worse than patients who did not.
Similar content being viewed by others
References
Hun JY (2016) Epidemiology and etiology of sarcomas. Surg Clin North Am 96:901–914
Ross JA, Severson RK, Davis S, Brooks JJ (1993) Trends in the incidence of soft tissue sarcomas in the United States from 1973 through 1987. Cancer 72:486–490
Levi F, Vecchia CL, Randimbison L, Te VC (1999) Descriptive epidemiology of soft tissue sarcomas in Vaud, Switzerland. Eur J Cancer 35:1711–1716
Gustafson P (1994) Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop Scand Suppl. 259:1–31
Zahm SH, Fraumeni JF Jr (1997) The epidemiology of sofi tissue sarcoma. Semin Oncol 24:504–514
Abarca T, Gao Y, Monga V, Tanas MR et al (2018) Improved survival for extremity soft tissue sarcoma treated in high-volume facilities. J Surg Oncol 117(7):1479–1486
Sim FH, Edmonson JH, Wold LE (1993) Soft-tissue sarcoma. Clin Orthop Rel Res 289:106–112
Berlin O, Stener B, Angervall L, Kindblom LG, Markhede G, Oden A (1990) Surgery of soft tissue sarcoma in the extremities: a multivariate analysis of the 6–26 year prognosis in 137 patients. Acta Orthop Scand 53:475–486
Gaynor JJ, Tan CC, Casper ES, Collin CF, Friedrich C, Shiu M, Hajdu SI et al (1992) Refinement of clinicopathologic staging for localised soft tissue sarcoma of the extremity: a study of 423 adults. J Clin Oncol 10:1317–1329
Clark MA, Fisher C, Judson I, Thomas JM (2005) Soft-tissue sarcomas in adults. N Engl J Med 353:701–711
Woll PJ, Reichardt P, Le Cesne A, Bonvalot S, Azzarelli A, Hoekstra HJ, EORTC Soft Tissue and Bone Sarcoma Group and the NCIC Clinical Trials Group Sarcoma Disease Site Committee et al (2012) Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicenterrandomised controlled trial. Lancet Oncol 13:1045–1054
Zhao R, Yu X, Feng Y, Wang J, Mao Y, Yin W et al (2018) The influence of anatomoic location on outcomes in patients with localized primary soft tissue sarcoma. Jpn J Clin Oncol 48(9):799–805
Sinha S, Peach AH (2010) Diagnosis and management of soft tissue sarcoma. BMJ 341:c7170
Kane JM 3rd (2004) Surveillance strategies for patients following surgical resection of soft tissue sarcomas. Curr Opin Oncol 16:328–332
Patel SR, Zagars GK, Pisters PW (2003) The follow-up of adult soft-tissue sarcomas. Semin Oncol 30:413–416
Jacobs AJ, Michels R, Stein J, Levin AS (2015) Improvement in overall survival from extremity soft tissue sarcoma over twenty years. Sarcoma 2015:1–9
Anonymous. Adjuvant chemotherapy for localized resectable soft tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet. 1997; 350(9092):1647–54.
Lewis JJ, Brennan MF (1996) Soft tissue sarcomas. Curr Probl Surg 33(10):817–872
Peiper M, Zurakowski, Zoring C (1997) Survival in primary soft tissue sarcoma of the extremities and trunk. Langenbecks Arh Chir. 382:203–208
Schreiber D, Rineer J, Katsoulakis E, Sroufe RL, Lange CS, Nwokedi E et al (2012) Impact of postoperative radiation on survival for high-grade soft tissue sarcoma of the extremities after limb sparing radical resection. Am J Clin Oncol 35(1):13–17
Zagars GK, Ballo MT (2003) Significance of dose in postoperative radiotherapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys 56(2):473–481
Gerrand CH, Wunder JS, Kandel RA, O’Sullivan B, Catton CN, Bell RS et al (2001) Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence. J Bone Joint Surg Br 83(8):1149–1155
Kawaguchi N, Ahmed AR, Matsumoto S, Manabe J, Matsushita Y (2004) The concept of curative margin in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res. 419:165–72
Cakır S, Dincbas FO, Uzel O, Koca S, Okkan S (1995) Multivariate analysis of prognostic factors in 75 patients with soft tissue sarcoma. Radiother Oncol 37(1):10–16
Trovik CS, Bauer HC, Berlin O, Tukiainen E, Erlanson M, Gustafson P et al (2001) Local recurrence of deep-seated, high grade, soft tissue sarcoma:459 patients from the Scandinavian Sarcoma Group Register. Acta Ortop Scand 72(2):160–166
Venkatesan M, Richards CJ, McCulloch TA, Perks AG, Raurell A (2012) Ashford RU; East Midlands Sarcoma Service. Inadvertent surgical resection of soft tissue sarcomas. Eur J Surg Oncol 38(4):346–51
Chandrasekar CR, Wafa H, Grimer RJ, Carter SR, Tillman RM, Abudu A (2008) The effect of an unplanned excision of a soft-tissue sarcoma on prognosis. J Bone Joint Surg Br 90:203–208
Bianchi G, Sambri A, Cammelli S, et al. Impact of residual disease after ‘unplanned excision’ of primary localized adult soft tissue sarcoma of the extremities: evaluation of 452 cases at a single institution. Musculoskelet Surg 2017.
Peabody TD, Monson D, Montag A, Schell MJ, Finn H (1994) A comparison of the prognosis for deep and subcutaneous sarcomas of the extremities. J Bone J Surg 76:1167–1173
Ogura K, Higashi T, Kawai A (2017) Statistics of soft-tissue sarcoma in Japan: report from bone and soft tissue tumor registry in Japan. J Orthop Sci 22:755–764
Italiano A, Mathoulin-Pelissier S, Cesne AL et al (2011) Trends in survival for patients with metastatic soft-tissue sarcoma. Cancer 117(5):1049–1054
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Garg, L., Pruthi, M., Batra, U. et al. Analysis of Clinical Outcomes of Patients with Soft Tissue Sarcoma. Indian J Surg Oncol 13, 518–524 (2022). https://doi.org/10.1007/s13193-022-01510-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-022-01510-0